{"id":1859,"date":"2026-11-06T17:58:13","date_gmt":"2026-11-06T17:58:13","guid":{"rendered":"https:\/\/homelymd.com\/blogs\/?p=1859"},"modified":"2026-11-06T17:58:15","modified_gmt":"2026-11-06T17:58:15","slug":"launch-peptide-brand-7-days-white-label-telehealth-checklist","status":"publish","type":"post","link":"https:\/\/homelymd.com\/blogs\/launch-peptide-brand-7-days-white-label-telehealth-checklist\/","title":{"rendered":"How to Launch a Peptide Brand in 7 Days: The White-Label Telehealth Checklist\u00a0"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">You can take a branded peptide program from decision to live platform in as little as seven days on a <a href=\"https:\/\/homelymd.com\/white-label-telehealth-platform\"><strong>white-label telehealth platform<\/strong><\/a>, subject to onboarding and approvals. But the speed only holds if you make the legal and compliance decisions in the right order. This checklist gives you the day-by-day sequence, and covers the parts most launch guides skip: the federal peptide policy&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">released in October 2026, legal structure and fee rules, creator and affiliate guardrails, advertising claims, and the math.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">If you want to <a href=\"https:\/\/homelymd.com\/blogs\/what-do-you-need-to-start-a-peptide-clinic\/\"><strong>launch a peptide brand<\/strong><\/a>, add <a href=\"https:\/\/homelymd.com\/blogs\/telehealth-peptide-therapy-online-care\/\"><strong>telehealth peptide programs<\/strong><\/a> <strong><\/strong>to an existing clinic or audience, or learn <a href=\"https:\/\/homelymd.com\/blogs\/what-do-you-need-to-start-a-peptide-clinic\/\"><strong>how to start a peptide therapy business<\/strong><\/a> <strong><\/strong>without building technology, hiring providers, and signing pharmacy and lab contracts yourself, start here.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>What &#8220;7 days&#8221; means, and what it doesn&#8217;t&nbsp;<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Included:<\/strong> platform configuration, brand setup, intake and consent, provider and pharmacy workflow, lab ordering, claims review, and a tested soft launch.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Not guaranteed by the platform:<\/strong> advertising-platform certification, payment-processor approval, attorney turnaround, and adding new states. These can take longer, so plan paid ads for after week one and soft-launch to an audience you already own.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Faster path:<\/strong> Homely MD offers an accelerated setup of as little as four hours for eligible businesses with the necessary assets and information ready.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>What changed on October 28, 2026&nbsp;<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">On October 28, 2026, HHS released a draft enforcement discretion policy (published in the Federal Register on October 30). It says HHS does not intend to take enforcement action against a state-licensed pharmacy, federal facility, or licensed physician that compounds a drug using one of six peptides, when ten conditions are all met. The six are <strong>BPC-157, Epitalon, KPV, MOTS-c, Semax, and TB-500<\/strong>.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 It applies to <strong>503A pharmacies only<\/strong>, with a valid patient-specific prescription. It does not cover 503B outsourcing facilities or research-use-only products.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 It is <strong>not an FDA approval<\/strong>, does not add the peptides to the 503A bulks list, and is not binding on HHS or the public. HHS can change it, and it lasts until each peptide is addressed in a final rule.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>State law still applies.<\/strong> State medical and pharmacy boards are not bound by it.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 Comments were due <strong>November 13, 2026<\/strong>. FDA&#8217;s advisory committee is also scheduled to review five more peptides in February 2027: Cathelicidin, GHK-Cu, Dihexa acetate, Melanotan II, and PEG-MGF.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Practically, this gives telehealth peptide programs <strong><\/strong>a written federal framework for six peptides, but one with strings attached. Peptides outside the six, such as CJC-1295, ipamorelin, AOD-9604, and emideltide, are not covered by it, so treat them as a separate regulatory question.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Step zero: choose your launch model&nbsp;<\/strong><\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Model&nbsp;<\/strong><\/td><td><strong>Who owns brand and&nbsp;<\/strong><strong>patient data<\/strong><\/td><td><strong>Speed&nbsp;<\/strong><\/td><td><strong>Best for<\/strong><\/td><\/tr><tr><td>Build it yourself&nbsp;<\/td><td>You, fully&nbsp;<\/td><td>Slowest. You hire&nbsp;providers, sign pharmacies and labs, and build the&nbsp;technology.<\/td><td>Well-funded operators with a clinical team<\/td><\/tr><tr><td>Revenue-share or&nbsp;affiliate platform<\/td><td>Check the contract. Some platforms keep the patient relationship.<\/td><td>Fast to start&nbsp;<\/td><td>Testing demand. Review the fee structure with&nbsp;counsel (see Day 1).<\/td><\/tr><tr><td>API integration&nbsp;<\/td><td>You&nbsp;<\/td><td>Fast if you already have a site or app<\/td><td>Existing brands that want a clinical engine behind their own front end<\/td><\/tr><tr><td>Full white-label&nbsp;<\/td><td>You&nbsp;<\/td><td>As little as 7 days, subject to onboarding and&nbsp;approvals<\/td><td>New brands, clinics, med spas, wellness creators<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Homely MD supports two launch models: API integration with an existing website, or a complete white-label platform. In both, the customer owns the brand, patient relationships, and patient data, with a free machine-readable data export within 30 days of termination.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>The 7-day launch checklist&nbsp;<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Day 0: Before the clock starts&nbsp;<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Assets and decisions are what make a fast launch possible.&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\u00a0Brand name, domain, logo, colors, and brand voice are final.\u00a0<\/li>\n\n\n\n<li>Choose one starting protocol from the six covered peptides, and list the states you plan to serve first.\u00a0<\/li>\n\n\n\n<li>Book a health care regulatory attorney for two reviews: Day 1 (structure) and Day 5 (marketing).\u00a0<\/li>\n\n\n\n<li>Gather the business documents your platform onboarding will ask for.\u00a0<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Day 1: Lock your model and legal structure&nbsp;<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Decide who does what before anything is built.&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\u00a0Pick API integration or full white-label.<\/li>\n\n\n\n<li>Have counsel confirm how clinical and business roles are split in your launch states. The <strong>corporate practice of medicine<\/strong> doctrine generally keeps non-clinicians out of clinical decisions, and rules differ by state. California, Texas, and New York are known for strong doctrines.\u00a0<\/li>\n\n\n\n<li>Keep brand-side roles to marketing, technology, and administration. Licensed clinicians decide diagnosis, protocols, and prescribing.\u00a0<\/li>\n\n\n\n<li>Decide how any partner, coach, or affiliate gets paid, and get counsel&#8217;s approval <strong>before<\/strong> you promise a percentage (see the fee table below).\u00a0<\/li>\n\n\n\n<li>Start with states where you are clearly compliant and expand deliberately. Health lawyers note that regulators look at who actually controls care, not just who owns the company.\u00a0<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Day 2: Pharmacy and formulary, using the 10-condition test&nbsp;<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Turn HHS&#8217;s conditions into a vendor-diligence request.&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Confirm your pharmacy is a state-licensed <strong>503A<\/strong> pharmacy, and that your peptide and route match the policy&#8217;s appendix.\u00a0<\/li>\n\n\n\n<li>Send the diligence request in the table below and get the answers in writing. [ ] Keep launch products to a <strong>single active ingredient<\/strong>. Blends and stacks fall outside the policy.\u00a0<\/li>\n\n\n\n<li>Decide which peptides stay out of the launch menu for now.<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>HHS condition&nbsp;<\/strong><\/td><td><strong>What to ask your pharmacy to show you<\/strong><\/td><\/tr><tr><td>Peptide and identity&nbsp;<\/td><td>The peptide is one of the six, with the identity and route listed in the policy&#8217;s appendix<\/td><\/tr><tr><td>Registered source, valid COA&nbsp;<\/td><td>Bulk substance from an FDA-registered facility, with a valid certificate of analysis<\/td><\/tr><tr><td>Original manufacturer&nbsp;<\/td><td>Manufacturer is FDA-registered and cGMP-compliant, with its physical location on the COA; any reseller or repacker has validated both<\/td><\/tr><tr><td>Reporting&nbsp;<\/td><td>A process to report serious adverse events and quality issues to FDA MedWatch and to the relevant states, and patient labeling that explains how to report<\/td><\/tr><tr><td>Label statement&nbsp;<\/td><td>Label reads: This is a compounded drug product. Not for resale.<\/td><\/tr><tr><td>Single active ingredient&nbsp;<\/td><td>One API only<\/td><\/tr><tr><td>Oral forms&nbsp;<\/td><td>Documentation that the formulation achieves adequate oral bioavailability in humans<\/td><\/tr><tr><td>Device&nbsp;<\/td><td>Only an FDA 510(k)-cleared syringe is co-packaged or included<\/td><\/tr><tr><td>Other FD&amp;C Act requirements&nbsp;<\/td><td>Sanitary compounding and a valid patient-specific prescription<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Day 3: Clinical protocol, labs, and consent&nbsp;<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The brand supports the protocol. The clinicians own it.&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Set intake questions and contraindication screening with your clinical team.\u00a0<\/li>\n\n\n\n<li>Map baseline and follow-up labs. Homely MD includes five ready-built panels (TRT, HRT, Comprehensive, Peptide, and BPC), ordered and resulted in the same chart.\u00a0<\/li>\n\n\n\n<li>Write informed consent in plain language: the product is compounded, it is <strong>not FDA-approved<\/strong>, and the evidence is limited. FDA&#8217;s own reviewers recommended against adding these peptides to the bulks list, citing limited human clinical evidence.\u00a0<\/li>\n\n\n\n<li>Define the monitoring and follow-up schedule.\u00a0<\/li>\n\n\n\n<li>Write the adverse event procedure: who reports to MedWatch and to the states, how patients are told to report, and how complaints are logged.\u00a0<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Day 4: Configure your brand, site, and pricing&nbsp;<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Make the patient experience yours.&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\u00a0Configure your white-label patient portal, domain, and branding. The platform includes dynamic intake, scheduling, charting, e-prescribing, and unlimited video, audio, and chat.\u00a0<\/li>\n\n\n\n<li>Set price, subscription terms, and refund and cancellation terms.\u00a0<\/li>\n\n\n\n<li>Add the required notices: telehealth consent, privacy policy, and plain disclosure that the products are compounded and not FDA-approved.\u00a0<\/li>\n\n\n\n<li>Build your <strong>claims library<\/strong> (see the Say \/ Don&#8217;t say table below) and write site copy only from it.\u00a0<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Day 5: Marketing guardrails and creator program&nbsp;<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Set the rules before anyone posts.&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Give every creator, coach, and affiliate the claims library and a one-page do\/don&#8217;t sheet. \u00a0<\/li>\n\n\n\n<li>Require <strong>clear disclosure of every paid relationship<\/strong>: commissions, free product, or affiliate links. This is a core FTC endorsement requirement.\u00a0<\/li>\n\n\n\n<li>Keep ad tracking pixels off intake and logged-in pages, and have privacy counsel review your tracking setup, since health information can be exposed through ad technology.\u00a0<\/li>\n\n\n\n<li>Start any ad-platform certification your channels require. Industry guides commonly report that prescription-adjacent advertisers need LegitScript certification, with review times of a few weeks. Plan paid ads after week one.\u00a0<\/li>\n\n\n\n<li>Second attorney review of site copy, creator materials, and affiliate terms.\u00a0<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Day 6: Test the whole journey&nbsp;<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Find the problems before a patient does.&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Run a test patient from first click through intake, clinician review, e-prescription, pharmacy order, labs, and delivery (including cold-chain shipping where required).<\/li>\n\n\n\n<li>Check that labels, consent screens, and disclosures show the exact required text.<\/li>\n\n\n\n<li>Run an adverse event drill and a refund test.\u00a0<\/li>\n\n\n\n<li>Confirm analytics capture marketing results without exposing patient health information.\u00a0<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Day 7: Soft launch and monitoring&nbsp;<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Start small, with an audience you already own.&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Open to your email list, community, or existing clients in a limited set of states. [ ] Track lead-to-consult rate, consult-to-prescription rate, refill rate, refunds, and adverse event reports.\u00a0<\/li>\n\n\n\n<li>Set a weekly policy watch: the HHS policy final status, any FDA proposed rule, and the February 2027 advisory committee meeting.\u00a0<\/li>\n\n\n\n<li>After week one: add certified paid ads, new states, and a second service line. Homely MD supports eight service lines with no additional per-service-line charge.\u00a0<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Say \/ Don&#8217;t say: a claims library to start from&nbsp;<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">In September 2025, FDA and HHS announced a crackdown on misleading drug ads and sent warning letters to telehealth sellers of compounded GLP-1s. FDA treated flagged ads as misbranding. Flagged examples included &#8220;same active ingredient as&#8221; a brand-name drug, &#8220;generic&#8221; labels using brand names, and &#8220;clinically proven ingredients.&#8221; The same logic is likely to be applied to peptide marketing, so write as if it will be.&nbsp;<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Say&nbsp;<\/strong><\/td><td><strong>Don&#8217;t say<\/strong><\/td><\/tr><tr><td>Prescribed by a licensed clinician after an evaluation&nbsp;<\/td><td>FDA-approved, FDA-cleared, or &#8220;now legal&#8221;<\/td><\/tr><tr><td>Compounded for you by a licensed pharmacy, not FDA-approved<\/td><td>Same as, or generic version of, a brand-name drug<\/td><\/tr><tr><td>Your clinician decides if this is right for you&nbsp;<\/td><td>Guaranteed results, or promises to treat, cure, or prevent a condition<\/td><\/tr><tr><td>Results vary. Evidence for these peptides is limited.&nbsp;<\/td><td>Clinically proven, or any claim you can&#8217;t substantiate<\/td><\/tr><tr><td>Sponsored: I earn a commission if you sign up&nbsp;<\/td><td>Undisclosed affiliate links or paid testimonials<\/td><\/tr><tr><td>Prescription required. Not available in all states.&nbsp;<\/td><td>Research-use-only, &#8220;not for human consumption,&#8221; or lab-grade wording<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Peptide therapy program for wellness coaches&nbsp;<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">A <a href=\"https:\/\/homelymd.com\/brands\"><strong>peptide therapy program for wellness coaches<\/strong><\/a> <strong><\/strong>works when the coach stays in the coach lane and the clinical work stays with licensed clinicians. Your audience trusts you, and that trust is also what makes compliance matter.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>A coach can&nbsp;<\/strong><\/td><td><strong>A coach shouldn&#8217;t<\/strong><\/td><\/tr><tr><td>Own the brand and the client experience&nbsp;<\/td><td>Diagnose, recommend a peptide, or suggest a dose<\/td><\/tr><tr><td>Share general education about the program and lifestyle habits, with accurate disclosures<\/td><td>Promise outcomes, or say a peptide treats a condition<\/td><\/tr><tr><td>Refer clients to the program&#8217;s licensed clinicians&nbsp;<\/td><td>Tell clients to stop or change a prescribed medication<\/td><\/tr><tr><td>Share results only with accurate, disclosed context&nbsp;<\/td><td>Post testimonials that imply typical results, or hide paid relationships<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Peptide therapy program for affiliate marketers&nbsp;<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">A peptide therapy program for affiliate marketers has two distinct paths, and the choice decides who carries the legal risk.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Referral partner.<\/strong> You send traffic to someone else&#8217;s brand and earn a payment. The brand owns the patient relationship and the advertising responsibility, and the way you are paid matters (see below).&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Brand owner.<\/strong> You build your own brand on a white-label platform and own the audience, patient relationships, and data. You also own the advertising claims and disclosure obligations, because FDA has pursued telehealth sellers directly over their ads.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">How you get paid is a legal question, not just a business one. Health lawyers describe management and referral fees on a spectrum of risk:&nbsp;<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Fee structure&nbsp;<\/strong><\/td><td><strong>Relative risk in&nbsp;<\/strong><strong>strict-CPOM states<\/strong><\/td><td><strong>Note<\/strong><\/td><\/tr><tr><td>Flat monthly fee tied to services provided&nbsp;<\/td><td>Lowest&nbsp;<\/td><td>Set in advance, at fair market value, in a written agreement<\/td><\/tr><tr><td>Expense reimbursement plus a fixed markup<\/td><td>Lower&nbsp;<\/td><td>More widely accepted, though costs fluctuate<\/td><\/tr><tr><td>Hybrid (expenses plus a percentage of revenue)<\/td><td>Moderate&nbsp;<\/td><td>Reduces but may not eliminate percentage-based risk<\/td><\/tr><tr><td>Percentage of revenue or per-patient referral payments<\/td><td>Higher&nbsp;<\/td><td>Some states prohibit or restrict fees tied to volume, or apply fee-splitting or referral-payment rules<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Where federal healthcare programs are involved, payments tied to referrals can also implicate the Anti-Kickback Statute and Stark Law. Have counsel approve any payout structure before you recruit affiliates.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>The math: a worked example you can re-run&nbsp;<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Most guides quote margins without showing the math. Here is the formula, with <strong>illustrative<\/strong> numbers only. Replace each line with your own quote from your pharmacy, platform, and payment processor.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Line (per patient, per month)&nbsp;<\/strong><\/td><td><strong>Illustrative value&nbsp;<\/strong><\/td><td><strong>How to calculate<\/strong><\/td><\/tr><tr><td>Patient price&nbsp;<\/td><td>$400&nbsp;<\/td><td>Your monthly program price<\/td><\/tr><tr><td>Pharmacy cost&nbsp;<\/td><td>-$100&nbsp;<\/td><td>From your pharmacy price list<\/td><\/tr><tr><td>Payment processing (3%%)&nbsp;<\/td><td>-$12&nbsp;<\/td><td>Price x your processor&#8217;s rate<\/td><\/tr><tr><td>Clinical and platform cost&nbsp;<\/td><td>-$90&nbsp;<\/td><td>From your Homely MD pricing<\/td><\/tr><tr><td>Refund and chargeback reserve (3%%)&nbsp;<\/td><td>-$12&nbsp;<\/td><td>Price x your expected rate<\/td><\/tr><tr><td>Support&nbsp;<\/td><td>-$8&nbsp;<\/td><td>Your cost per patient<\/td><\/tr><tr><td><strong>Contribution per patient&nbsp;<\/strong><\/td><td><strong>$178 (44.5%)&nbsp;<\/strong><\/td><td>Price minus all of the above<\/td><\/tr><tr><td>Break-even patients for $3,000 fixed monthly cost<\/td><td>17 patients&nbsp;<\/td><td>Fixed cost \/ contribution, rounded up<\/td><\/tr><tr><td>Payback on $200 acquisition cost&nbsp;<\/td><td>1.1 months&nbsp;<\/td><td>Acquisition cost \/ contribution<\/td><\/tr><tr><td>Value if an average patient stays 4 months&nbsp;<\/td><td>$712 (3.6x acquisition cost)<\/td><td>Contribution x months \/ acquisition cost<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">These are assumptions for illustration, not results or promises. Retention and acquisition cost are the numbers most likely to move your outcome, so test them in your soft launch.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Six mistakes that stall a peptide launch&nbsp;<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Launching with a blend.<\/strong> The policy requires a single active ingredient.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Calling peptides &#8220;FDA-approved&#8221; or &#8220;now legal.&#8221;<\/strong> They remain unapproved drugs. \u2022 <strong>Sourcing research-use-only products.<\/strong> The policy gives them no protection, and FDA has already sent warning letters to online peptide vendors.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Promising affiliates a percentage before counsel signs off.<\/strong> It can trigger state fee-splitting questions.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Putting ad pixels on intake pages.<\/strong> It risks exposing health information.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Counting seven days without approvals.<\/strong> Processor, ad-platform, and attorney timelines are real. Start them on Day 0.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Why launch with Homely MD&nbsp;<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/homelymd.com\/\">Homely MD<\/a> is a technology-enabled care network that connects nurse practitioners, RNs, LPNs, and clinics nationwide on one platform. It is a B2B service: your brand is out front, and the clinical engine runs underneath. One contract and one invoice cover:&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Platform:<\/strong> white-label patient front end and provider backend with patient portal, dynamic intake, scheduling, charting, e-prescribing, and unlimited video, audio, and chat. \u2022 <strong>Providers:<\/strong> licensed, credentialed clinicians across all 50 states, with malpractice coverage carried by Homely MD ($1M minimum per occurrence).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Pharmacy:<\/strong> 24+ 503A compounding pharmacy partners, with patient-specific compounding and direct-to-patient delivery.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <strong>Labs:<\/strong> five ready-built panels covering up to 52 biomarkers.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Which peptides, routes, and states are available at launch depends on pharmacy-partner capabilities and the conditions above, so confirm them during onboarding.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Ready to launch a telehealth peptide therapy program?&nbsp;<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">\u2022 <a href=\"https:\/\/homelymd.com\/contact\">Talk to Homely MD about launching your branded program<\/a> in as little as seven days, subject to onboarding and approvals.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Frequently asked questions&nbsp;<\/strong><\/h3>\n\n\n\n<h4 class=\"wp-block-heading\">How long does it take to launch a peptide brand on a white-label telehealth platform?\u00a0<br><\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Homely MD supports platform go-live in as little as seven days, subject to required onboarding and approvals, with an accelerated setup of as little as four hours for eligible businesses that have their brand assets and information ready. Items outside the platform&#8217;s control, such as advertising-platform certification, payment-processor approval, and expansion into more states, can take longer, so most brands soft-launch to an owned audience first and add paid ads afterward.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Which peptides can a telehealth brand offer under HHS&#8217;s October 2026 policy?\u00a0<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\"><br>As of November 6, 2026, HHS&#8217;s draft enforcement discretion policy covers six peptides compounded under section 503A: BPC-157, Epitalon, KPV, MOTS-c, Semax, and TB-500, each only in the routes listed in the policy. HHS does not intend to act against qualifying compounders if all ten conditions are met, including a patient-specific prescription and a single-ingredient product. The peptides remain unapproved drugs, and state laws still apply.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Can a wellness coach or affiliate marketer launch a peptide therapy program without a medical license?<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\"><br>In many cases, yes, as a brand owner or marketer, but never as the clinician. Licensed\u00a0clinicians must make every diagnostic and prescribing decision, while the brand handles marketing, technology, and administration. Corporate practice of medicine rules vary by state, and payments that rise with patient volume can raise fee-splitting questions in some states. Paid relationships must be clearly disclosed, and a health care attorney should review the structure before launch.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">What is included in a white-label telehealth platform for a peptide program?<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\"><br>Homely MD&#8217;s white-label telehealth platform bundles four layers under one contract and one invoice: a branded patient portal and provider backend (intake, scheduling, charting, e-prescribing, video, audio, and chat); licensed clinicians across all 50 states, with malpractice coverage carried by Homely MD; 24+ 503A compounding pharmacy partners; and integrated lab panels, including peptide and BPC panels. The customer owns the brand, patient relationships, and patient data.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">What can a telehealth brand say when advertising compounded peptides?<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\"><br>Claims must be truthful, substantiated, and must not imply FDA approval. FDA&#8217;s September 2025 warning letters to telehealth sellers of compounded GLP-1s flagged claims such as &#8220;same active ingredient as&#8221; a brand-name drug and &#8220;clinically proven ingredients,&#8221; treating them as misbranding. Avoid &#8220;FDA-approved,&#8221; &#8220;now legal,&#8221; cure claims, and undisclosed paid endorsements. Describe peptides as prescribed, compounded, patient-specific, and not FDA-approved.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>You can take a branded peptide program from decision to live platform in as little as seven days on a white-label telehealth platform, subject to onboarding and approvals. But the speed only holds if you make the legal and compliance decisions in the right order. This checklist gives you the day-by-day sequence, and covers the [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":1861,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[125],"tags":[127,124,128,98,126,95],"class_list":["post-1859","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-launch-peptide-brand","tag-how-to-start-a-peptide-therapy-business","tag-launch-peptide-brand","tag-peptide-therapy-program-for-wellness-coaches","tag-start-a-telehealth-business","tag-telehealth-peptide-programs","tag-white-label-telehealth-platform"],"_links":{"self":[{"href":"https:\/\/homelymd.com\/blogs\/wp-json\/wp\/v2\/posts\/1859","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/homelymd.com\/blogs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/homelymd.com\/blogs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/homelymd.com\/blogs\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/homelymd.com\/blogs\/wp-json\/wp\/v2\/comments?post=1859"}],"version-history":[{"count":1,"href":"https:\/\/homelymd.com\/blogs\/wp-json\/wp\/v2\/posts\/1859\/revisions"}],"predecessor-version":[{"id":1860,"href":"https:\/\/homelymd.com\/blogs\/wp-json\/wp\/v2\/posts\/1859\/revisions\/1860"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/homelymd.com\/blogs\/wp-json\/wp\/v2\/media\/1861"}],"wp:attachment":[{"href":"https:\/\/homelymd.com\/blogs\/wp-json\/wp\/v2\/media?parent=1859"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/homelymd.com\/blogs\/wp-json\/wp\/v2\/categories?post=1859"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/homelymd.com\/blogs\/wp-json\/wp\/v2\/tags?post=1859"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}